Many PBA patients may remain undiagnosed, but you can change that.2
Approximately 2 million Americans with neurologic conditions or brain injuries may experience PBA symptoms of uncontrollable laughing and/or crying.2 Their unpredictable episodes can have a substantial impact – but PBA doesn't have to go untreated.5
NUEDEXTA is the first and only FDA-approved treatment for PBA.1
PBA occurs in patients with an underlying neurologic condition or brain injury. It is characterized by involuntary, sudden, frequent episodes of laughing and/or crying that are exaggerated or incongruent with a patient's underlying mood.2-4
Impact of PBA
See how PBA can affect the lives of patients already experiencing serious neurologic disorders.
Learn the signs and symptoms of PBA and the steps to diagnose it.
Safety & Efficacy
Review NUEDEXTA's clinical trial results demonstrating its effectiveness in reducing PBA episodes.6,7